What the future emergence of Amazon Pharmacy and the company’s aim to own the health experience may mean for pharma manufacturers’ engagement strategies and role in Rx delivery.
Howard Deutsch
Advertisement
Articles by Howard Deutsch
Pharmaceutical Executive
Oncology-market access doesn’t “just happen” anymore. As competition in the U.S. health-care market only continues to intensify, oncology-drug companies will need a good corporate strategy to ensure physician uptake and payer coverage of therapies.
Advertisement
Latest Updated Articles
- Three Capabilities You Must Build Today to Ensure Market Access Tomorrow
November 12th 2013
Advertisement
Advertisement
Trending on PharmExec
1
Pfizer Receives Unsolicited Mini-Tender Offer for 1 Million Shares from Tutanota: Report
2
Bayer Shares Briefly Dip After Activist Investor Offloads Millions of Dollars in Company Stock
3
Gilead Sciences Enters $2.1 Billion Definitive Agreement to Acquire Ouro Medicines
4
Why CMS Is Tightening ASP Reporting and What Manufacturers Must Get Right
5